Spain's Grifols reports fivefold increase in 2012 profit
MADRID Feb 28 (Reuters) - Spanish pharmaceutical company Grifols reported a more than fivefold rise in full-year profit for 2012 to 257 million euros ($336.90 million), buoyed by its acquisition of U.S. firm Talecris last June and its wide geographic presence outside its depressed home market.
Barcelona-based Grifols said sales grew 46 percent year-on-year to reach 2.6 billion euros, in line with analyst expectations. ($1 = 0.7628 euros) (Reporting By Sonya Dowsett; Editing by Clare Kane)
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- U.S. immigration protesters drop U.S. border blockade plan
- About 60,000 Syrian Kurds flee to Turkey from Islamic State advance |
- Secret Service investigates after man jumps White House fence, reaches doors
- Kentucky firefighter dies after ice bucket challenge accident